Compare KOD & FBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KOD | FBNC |
|---|---|---|
| Founded | 2009 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | 2018 | 1995 |
| Metric | KOD | FBNC |
|---|---|---|
| Price | $38.89 | $56.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $35.43 | ★ $61.25 |
| AVG Volume (30 Days) | ★ 1.6M | 200.5K |
| Earning Date | 05-13-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.72% |
| EPS Growth | N/A | ★ 45.65 |
| EPS | N/A | ★ 2.68 |
| Revenue | N/A | ★ $67,623,000.00 |
| Revenue This Year | N/A | $37.82 |
| Revenue Next Year | N/A | $2.30 |
| P/E Ratio | ★ N/A | $20.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.92 | $35.14 |
| 52 Week High | $45.60 | $62.64 |
| Indicator | KOD | FBNC |
|---|---|---|
| Relative Strength Index (RSI) | 64.44 | 52.41 |
| Support Level | $21.82 | $45.57 |
| Resistance Level | $45.60 | $56.44 |
| Average True Range (ATR) | 3.61 | 1.20 |
| MACD | 1.72 | 0.38 |
| Stochastic Oscillator | 73.03 | 80.62 |
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing, and investment advisory services.